Fluvoxamine for COVID-19: A New Weapon in the Fight?

Share

Yale University

Dr. F. Perry Wilson is a world-renowned clinical researcher, epidemiologist and science communicator.

The antidepressant fluvoxamine appears to have some ability to prevent worsening in outpatients with COVID-19.